ChartRow logo
AGL
$91.72+3.25%
as of close, Oct 20, 2026
☾ AH $91.72 +3.25%
PeersEHCSPYQQQNVDAAAPLMSFT
Share this page

AGL financial statements

The full income statement, balance sheet, and cash-flow statement for agilon health inc. (AGL), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 16.5M2024-09 16.5M2024-12 16.5M2025-03 16.6M2025-06 16.6M2025-09 16.6M2025-12 16.6M2026-03 16.7M2026-06 16.8M+2.0% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue5.93B-2.1%6.06B+40.4%4.32B+80.7%2.39B+57.0%1.52B+24.9%
———2.83B+27.0%2.23B+74.7%
Selling, general & administrative239M-11.3%269M-5.9%286M+37.5%208M-51.4%428M+211.4%
General & administrative239M-11.3%269M-5.9%286M+37.5%208M-51.4%428M+211.4%
Amortization of intangibles13.4M+8.9%12.3M+53.8%8.00M+60.0%5.00M-39.0%8.20M-28.1%
Operating income-463M-58.6%-292M-25.8%-232M-120.3%-105M+71.7%-372M-556.8%
Interest expense6.64M+7.5%6.18M-7.2%6.66M+48.5%4.48M-27.0%6.15M-24.4%
Other non-operating income67.6M+96.1%34.5M+23.9%27.8M+99.9%13.9M+539.6%2.18M-11.6%
Equity-method income-1.83M-112.2%15.0M-9.1%16.5M+53.8%10.7M+258.4%-6.77M-1416.3%
Pre-tax income-404M-62.4%-249M-28.0%-194M-114.5%-90.7M+76.3%-383M-514.3%
Income tax1.25M-13.8%1.45M+83.4%791K-51.8%1.64M+85.1%886K+2.4%
-391M-50.4%-260M+0.9%-263M-146.4%-107M+73.8%-406M-576.9%
Income from continuing operations-405M-61.9%-250M-28.3%-195M-112.0%-92.0M+76.0%-384M
Discontinued operations—-9.82M+85.5%-67.5M-364.1%-14.6M+36.5%-22.9M-826.4%
Net income to non-controlling interest0.00-100.0%50.0K+124.2%-207K+33.4%-311K-3.7%-300K
Weighted-avg shares (basic)16.6M+0.7%16.4M+0.5%16.4M+0.2%16.3M+9.4%14.9M+15.3%
Weighted-avg shares (diluted)16.6M+0.7%16.4M+0.5%16.4M+0.2%16.3M+9.4%14.9M+15.3%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.10B-24.8%1.46B-1.5%1.48B+2.0%1.45B+6.1%1.37B+364.7%
Cash & equivalents174M-7.7%188M+75.0%108M-76.9%465M-55.3%1.04B+873.9%
Short-term investments———412M0.00
Accounts receivable674M-33.7%1.02B+7.9%942M+91.4%492M+67.8%293M+103.0%
Prepaid expenses138M+292.1%35.1M-17.3%42.5M+34.7%31.6M+66.4%19.0M+96.8%
1.27B-26.7%1.73B-0.4%1.74B+2.6%1.70B+7.0%1.59B+255.4%
Property, plant & equipment25.4M-9.8%28.2M+2.2%27.6M+38.3%19.9M+117.6%9.16M+41.9%
Operating lease right-of-use3.54M-59.7%8.78M-34.5%13.4M+11.6%12.0M+2.4%11.7M
Goodwill0.00-100.0%24.1M+0.0%24.1M+860.3%2.51M-94.0%41.5M+0.0%
Intangible assets65.7M-9.7%72.8M+14.1%63.8M+245.7%18.4M-66.7%55.4M-8.4%
Other non-current assets83.5M-44.8%151M+4.0%145M+37.3%106M-6.3%113M+158.5%
1.08B-6.6%1.15B+17.9%977M+82.6%535M+49.9%357M+33.8%
Accrued liabilities127M-42.1%220M-8.0%239M+34.9%177M+57.1%113M+16.1%
Short-term & current debt19.2M0.00-100.0%6.25M+25.0%5.00M+0.0%5.00M+64.4%
Current lease liability—2.46M-13.6%2.85M-17.5%3.45M—
1.14B-9.4%1.26B+17.0%1.08B+64.4%657M+32.8%495M+17.3%
Long-term debt15.8M-54.9%34.9M+8.0%32.3M-16.0%38.5M-11.3%43.4M-32.9%
Non-current lease liability1.83M-72.3%6.60M-39.5%10.9M+20.0%9.09M+15.0%7.90M+43.5%
Operating lease liability (total)—9.06M-34.1%13.8M+9.7%12.5M+11.8%11.2M+26.2%
Other non-current liabilities52.3M-31.3%76.1M+8.2%70.4M-14.7%82.5M-12.5%94.3M+4.7%
127M-73.1%471M-28.8%662M-36.4%1.04B-4.6%1.09B+483.5%
Common stock166K-96.0%4.12M+1.4%4.06M-1.5%4.12M+3.1%4.00M+60.4%
Additional paid-in capital2.10B+2.4%2.05B+3.4%1.99B-5.7%2.11B+3.0%2.05B+674.9%
Retained earnings-1.98B-24.7%-1.59B-19.6%-1.33B-24.7%-1.06B-11.1%-958M-73.7%
Accumulated other comprehensive income916K+1140.9%-88.0K+96.2%-2.30M+58.7%-5.56M0.00
Non-controlling interest—0.00+100.0%-818K-33.9%-611K-103.7%-300K
Total equity incl. non-controlling127M-73.1%471M-28.8%661M-36.5%1.04B-4.7%1.09B+483.4%
Total liabilities & equity1.27B-26.7%1.73B-0.4%1.74B+2.6%1.70B+7.0%1.59B+255.4%
Common shares issued16.6M+0.6%16.5M+1.4%16.3M-1.5%16.5M+3.1%16.0M+60.4%
Common shares outstanding16.6M+0.6%16.5M+1.4%16.3M-1.5%16.5M+3.1%16.0M+60.4%
Shares outstanding (cover)16.6M+0.6%16.5M+0.7%16.4M-0.9%16.5M+3.0%16.0M
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
-106M-83.1%-57.8M+63.0%-156M-19.4%-131M+11.7%-148M-178.5%
Depreciation & amortization28.6M+16.9%24.5M+21.3%20.2M+46.4%13.8M-6.1%14.7M+4.0%
Intangible amortization13.4M+8.9%12.3M+53.8%8.00M+60.0%5.00M-39.0%8.20M-28.1%
Share-based compensation49.1M-3.0%50.7M-27.1%69.5M+144.9%28.4M-90.3%292M+4271.9%
Deferred income taxes-240K-211.6%215K+113.4%-1.60M-402.5%530K+231.5%-403K-4577.8%
88.6M-36.7%140M+417.8%-44.0M+90.1%-444M-391.0%-90.5M-510.2%
Capital expenditure13.2M-0.1%13.3M-16.3%15.8M+2.6%15.4M+135.0%6.56M+269.8%
Free cash flow-119M-67.5%-71.0M+58.7%-172M-17.6%-146M+5.5%-155M-181.4%
Acquisitions0.000.00-100.0%45.3M0.000.00
Sales/maturities of investments194M-6.3%207M+26.1%164M——
-2.99M-15.9%-2.58M+98.7%-193M-788.4%28.1M-97.6%1.15B+4588.6%
Long-term debt issued0.000.000.000.00-100.0%100M
Long-term debt repaid0.00-100.0%3.75M-25.0%5.00M+0.0%5.00M-95.8%120M+3842.7%
Common stock issued0.00-100.0%1.17M-90.2%11.9M-64.1%33.1M+82.8%18.1M-47.4%
Common stock repurchased0.000.00-100.0%200M0.000.00-100.0%
Dividends paid0.000.000.000.000.00
Net change in cash-20.1M-125.3%79.5M+120.2%-393M——
Interest paid5.66M+23.2%4.60M-20.7%5.80M+57.9%3.67M-23.9%4.82M-31.9%
Income taxes paid576K-68.0%1.80M-66.7%5.40M+1.6%5.31M+192.1%1.82M+90850.0%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap286M-63.5%783M-84.6%5.10B-23.3%6.65B-38.6%10.8B
P/S0.0×-62.7%0.1×-90.8%1.4×-54.2%3.1×-57.0%7.1×
P/B2.3×+35.6%1.7×-71.5%5.8×-4.6%6.1×-38.3%9.9×
Source filing10-K10-K10-K10-K10-K

About this data

Source: AGL’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all AGL filings on SEC EDGAR → Not investment advice.